Effect of 2-methylaminoethyl-4,4′-dimethoxy-5,6,5′,6′- dimethylenedioxybiphenyl-2-carboxylic acid-2′-carboxylate monohydrochloride (DDB-S) on indocyanine green (ICG) clearance in rats

Archives of Pharmacal Research

Volumn 28, Issue 1, 2005, Pages 115-119

  Lee, Kyoung Jin ^a   Kim, Jae Ryung ^b   Lee, Chi Ho ^b  

^a Locus Pharmaceuticals   (United States)

^b Pusan National University   (South Korea)

Author keywords

Clearance; DDB S; Hepatic blood flow; ICG

Indexed keywords

BIPHENYL DERIVATIVE; DIMETHOXY BIPHENYL MONOCARBOXYLATE; INDOCYANINE GREEN;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; MALE; METABOLIC CLEARANCE RATE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BIPHENYL COMPOUNDS; INDOCYANINE GREEN; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 20344369310     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02975146     Document Type: Article

References (21)

1. Andersen, M. N. and Kuchiba, K., Measurement of acute change in liver function and blood flow. Arch. Surg., 100, 541-545 (1970).
2. Awani, W. M. and Bakker, L. J., Antipyrine, indocyanine green, and lorazepam determined in plasma by high-pressure lipuid chromatography. Clin. Chem., 35, 2124-2126 (1989).
3. Fleck, C. and Braunlich, H., Relation between renal and hepatic excretion of drugs. II. Age-dependence of phenol red excretion in comparison with those of p-aminohippurate and indocyanine green. Exp. Pathol., 29, 235- 247 (1986).
4. Joo, E. H. and Lee, Y. B., No effect of Diltiazem on the hepatic clearance of Indocyanine green in the rats. Arch. Pharm. Res., 21, 411-417 (1998).
5. Kim, S. G., Kim, H. J., Choi, S. H., and Ryu, J. Y., Inhibition of lipopolysaccharide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4.4-dimethoxy-5,6,5,6-dimethylene dioxybiphenyl-2,2- dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression. Liver, 20, 319-329 (2000).
6. Kim, Y. K., Synthesis and physicochemical properties of water-soluble DDB derivative. Master of Science Thesis, Pusan National University (1996).
7. Klaassen, C. D. and Plaa, G. L., Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs. Toxicol. Appl. Pharmacol., 15, 374-84 (1969).
8. Lee, H. S., Kim, Y. T., Jung, H. C., Yoon, Y. B., Song, I. S., and Kim, C. Y., Protective randomized controlled trial with diphenyl dimethyl dicarboxylate in chronic active liver diseases: the effect on lowering serum alanine aminotransferase levels. Kor. J. Int. Med., 40, 173-178 (1991).
9. Li, Y., Paranawithana, S. R., Yoo, J. S., Ning, S. M., Ma, B. L., Lee, M. J., Liu, G. T., and Yang, C. S., Induction of liver microsomal cytochrome P-450 2B1 by dimethyl diphenyl bicarboxylate in rats. Zhongguo Yao Li Xue Bao, 13, 485-490 (1992).
10. Liu, G. T., Pharmacological actions and clinical use of fructus schizandrae. Chin. Med. J (Engl)., 102, 740-749 (1989).
11. Liu, K. T. and Lesca, P., Pharmacological properties of dibenzo [a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. I. Interaction with rat liver cytochrome p-450 and inhibition of xenobiotic metabolism and mutagenicity. Chem. Biol. Interact., 39, 301-314 (1982).
12. Liu, K. T., Wang, G. F., Wei, H. L., Bao, T. T., and Song, Z. Y., A comparison of the protective action of biphenyl dimethyl dicarboxylate, trans-stilbene alcoholic extracts of Fructus shiznadrae and ganoderma against experimental liver injury in mice. Acta. Pharm. Sinica, 14, 598-604 (1979).
13. Liu, K. T., Wei, H. L., and Song, Z. Y., Further studies on the protective action of diphenyl dimethyl dicarboxylate (DDB) against experimental liver injury in mice. Acta. Pharm. Sinica, 17, 101-105 (1982).
14. Oh, S. Y., Lee, C. H., and Ku, Y. S., Pharmacokinetics and hepatoprotective effect of 2-methylaminoethyl-4,4′-dimethoxy-5,6,5′, 6′-dimethylenedioxybiphenyl-2-carboxylic acid-2-carboxylate monohydrochloride in rats with CCl4-induced acute hepatic failure. J. Pharm. Pharmacol., 52, 1099-1103 (2000).
15. Park, A. J., Synthesis of a water-soluble derivative of dimethyl dimethoxy Biphenylate and its preventive and therapeutic effect on liver cirrhosis. Ph. D. Thesis, Pusan National University (1999).
16. Qing, W. and Liu, G., Protective effect of dimethyl-4,4′-dimethoxy- 5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB) against carcinogen-induced rat liver nuclear DNA damage. Biomed. Environ. Sci., 5, 201-207 (1992).
17. Sato, N., Hayashi, N., Kawano, S., Kamada, T., and Abe, H., Hepatic hemodynamics in patients with chronic hepatitis or cirrhosis as assessed by organ-reflectance spectrophotometry. Gastroenterology, 84, 611-616 (1983).
18. Skak, C. and Keiding, S., Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver, 7, 155-162 (1987).
19. Suh, I. S., Studies on the metabolism and pharmacokinetics of dimethoxy biphenyl monocarboxylate HCl. Master of Science Thesis, Pusan National University (2000).
20. Tapalaga, D., Dumitrascu, D., Cotul, S., Stanciu, L., and Tamas, S., Colchicine treatment effects on liver cirrhosis assessed by liver blood flow measurements. Med. Interne., 24, 69-73 (1986).
21. Xie, J. X., Zhou, J., Zhang, C. Z., Yang, J. H., Jin, H. Q., and Chen, J. X., Synthesis of Schizandrin C analogs. Pharm. Factory Shanghai, 15, 306 (1981).